SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

Company Overview - SI-BONE, Inc. is a global leader in technology for the surgical treatment of sacropelvic disorders [2] - The company has supported over 3,900 surgeons in performing more than 100,000 sacropelvic procedures since pioneering minimally invasive surgery of the SI joint in 2009 [2] - SI-BONE has a strong clinical evidence base, including two randomized controlled trials and over 135 peer-reviewed publications [2] Upcoming Financial Results - SI-BONE will report its financial results for the third quarter of 2024 after market close on November 12, 2024 [1] - A conference call will be hosted by management at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day [1] - Investors can access the live audio of the webcast through the company's website, and it will be archived for at least 90 days [1]